Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Supply of Trivalent Influenza Vaccine (Adult Population)

Active

Federal

Response Deadline09/08/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Nac Pharmaceuticals, under the Department of Veterans Affairs, is seeking a subcontractor for the manufacture and supply of a trivalent influenza vaccine tailored for adults aged 36 months and older. The required vaccine must be provided in pre-filled single-dose syringes and must be free of latex and preservatives. All products must strictly adhere to FDA standards and WHO recommendations. This opportunity is categorized under NAICS code 325413. The solicitation was posted on August 25, 2026, with a response deadline set for September 8, 2026, at 7:30 PM.

General Info

Nac Pharmaceuticals seeks a subcontractor for adult trivalent influenza vaccine supply by September 8.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0035.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--2027-2028 Influenza Virus Vaccine

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 25

subcontract

Response DeadlineSep 8

Submission deadline

Response Deadline

09/08/2026, 07:30:00 PM UTCin 10 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and supply of latex- and preservative-free trivalent influenza vaccine in pre-filled single-dose syringes for adults (≥36 months), compliant with WHO recommendations and FDA standards.

Similar Contracts

Same NAICS industry code

TrueMark, TaqMan, Qubit, and Other Laboratory Consumables

Solicitation # N6311626Q0560

The Naval Health Research Center in San Diego, California, intends to award a sole-source contract to Fisher Scientific Company L.L.C. dba Fisher Healthcare under the statutory authority of 10 U.S.C. 3204(a)(1). This procurement is for a variety of laboratory consumables, including TrueMark, TaqMan, and Qubit assays, primers, controls, and PCR plates. The delivery schedule is specified as as soon as possible after the receipt of the order. Interested parties must be registered in the System for Award Management and complete all necessary FAR and DFARS representations and certifications. Submissions must reference solicitation number N6311626Q0560 and include the company name, full address, CAGE code, and point of contact information. The response deadline for this notice is September 5, 2026.

Naval Health Research Center

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26226Q1425

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking sources for Optilite analyzer reagents under solicitation number 36C26226Q1425. This sources-sought notice is categorized under NAICS code 325413 and is managed by Contract Specialist Carlos Magana. The place of performance for this requirement is located in Tucson, Arizona. Interested parties must submit their responses by the deadline of September 7, 2026, at 4:00 PM.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Solicitation 75H70726Q00104 - Laboratory Quality Control Materials - Zuni Comprehensive Community Health Center (ZCCHC)

Solicitation # Solicitation_75H70726Q00104

Solicitation 75H70726Q00104 is issued by the Indian Health Service Albuquerque Area Office to procure laboratory quality control materials and related support for the Zuni Comprehensive Health Center Laboratory in Zuni, New Mexico. This requirement is primarily set aside for Indian Small Business Economic Enterprises under the Buy Indian Act, utilizing a cascading set-aside structure that allows the government to consider other small business categories, such as SDVOSBs and HUBZone certified businesses, if a fair and reasonable price cannot be reached with an ISBEE. Interested vendors must submit a comprehensive quotation consisting of three volumes covering technical capability, past performance, and pricing for the base period and four option periods. Submissions must also include a signed SF 1449 and applicable Indian Economic Enterprise representations. The response deadline for this opportunity is September 3, 2026.

Albuquerque Area Indian Health Svc

POSTED

DEADLINE

6550-- Blood Bank Cost Per Test

Solicitation # 36C25726Q0870

Solicitation 36C25726Q0870 is a request for quotation for laboratory Blood Bank Cost Per Test services for the VA North Texas Healthcare System. This is an unrestricted, open market procurement under NAICS code 325413. The Department of Veterans Affairs will evaluate proposals based on technical acceptability, past performance, and price. Interested vendors must submit all required documentation to Teresa Arzola via email by September 8, 2026, at 9:00 AM CST. All inquiries must be submitted in writing by September 2, 2026. The contract is governed by FAR Part 12 for commercial items and includes various federal acquisition clauses and provisions regarding labor, trade agreements, and government contracting standards.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System

Solicitation # 36C26326Q0650_1

The Department of Veterans Affairs Network Contracting Office 23 intends to award a sole source contract to Siemens Healthcare Diagnostics, Inc. for FDA approved specimen validity and Fentanyl reagents. These supplies will be utilized by the Forensic Toxicology Laboratory at the Minneapolis VA Health Care System to perform Fentanyl testing and verify specimen validity through nitrite and creatinine assays. Although this is a notice of intent for a sole source award, interested parties may submit a capabilities statement by September 11, 2026, at 16:00 CT to demonstrate their ability to provide the required services. The government maintains full discretion on whether to compete the contract based on the responses received. If no viable alternatives are identified by the deadline, the Department of Veterans Affairs will proceed with negotiations exclusively with Siemens Healthcare Diagnostics, Inc.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

BioRad_Lab_Quality_Control_Reagents_Taos_Picuris_Service_Unit

Solicitation # 75H70726Q00102

Solicitation Number 75H70726Q00102 is a request for quotation for BioRad Laboratories Quality Control Reagents to support the Laboratory Department at the Taos-Picuris Indian Health Center in Taos, New Mexico. Issued by the Albuquerque Area Indian Health Service under the Department of Health and Human Services, this acquisition is conducted as a combined synopsis and solicitation for commercial products or services in accordance with FAR Part 12. This procurement is a total Indian Small Business Economic Enterprise set-aside under the Buy Indian Act, featuring a cascading set-aside structure that considers SDVOSBs, HUBZone small businesses, and small disadvantaged businesses if sufficient competition is not met. Interested parties must submit quotes via email to the Contract Administrator by 12:30 pm MDT on September 07, 2026, with all inquiries submitted by September 02, 2026. Offerors must provide self-certification of their status via the Indian Economic Enterprise Representation Form and maintain active registration in the System of Award Management.

Albuquerque Area Indian Health Svc

POSTED

DEADLINE

6550--Immunology Testing

Solicitation # 36C26226Q1412

The Department of Veterans Affairs, through Network Contract Office 22, is soliciting bids for the procurement of immunology testing reagents and supplies for the Greater Los Angeles Healthcare System. This combined contract, identified by solicitation number 36C26226Q1412 and NAICS code 325413, focuses on providing specific BioRad brand products and equipment, including ANA testing reagents, to be used on BioPlex instrumentation. The successful offeror will be responsible for supplying these materials while adhering to strict operational hours and comprehensive security requirements, including federal information security standards and personnel clearance protocols. The procurement process requires detailed company information and pricing for a specific list of Contract Line Item Numbers (CLINs) that outline the necessary part numbers and salient characteristics of the required BioRad equipment. Performance of the contract will take place in Los Angeles, California. Interested parties must submit their responses by September 2, 2026, to the primary point of contact, Contract Specialist Carlos Magana.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

NNMC Test Kits and Technical Services for Roche Equipment

Solicitation # IHS1520579

The Navajo Area Indian Health Service Shiprock Service Unit intends to award a sole source, firm-fixed-price contract to Roche Diagnostics Corporation for test kits, supplies, and technical services. This restriction of competition is based on the fact that Roche Diagnostics is the only vendor capable of providing materials compatible with the equipment currently installed at the facility. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and will be conducted using simplified procedures. The period of performance is set for 12 months from the date of the award. While this notice is not a formal solicitation, interested vendors may submit capability statements to Bertina Jones by September 11, 2026, at 10:00 am MDT. The government will use any received information to determine if a competitive procurement is necessary, though a formal solicitation will not be issued.

Navajo Area Indian Health Svc

POSTED

DEADLINE

Primary Human Trophoblast Cells

Solicitation # 75F40126Q134903

The Department of Health and Human Services, through the FDA Office of Acq Grant Svcs, is seeking the procurement of Primary Human Trophoblast Cells under solicitation number 75F40126Q134903. This combined solicitation is categorized under NAICS code 325413 and is managed by Howard Nesmith. The opportunity was posted on August 26, 2026, with a response deadline of August 31, 2026. While the contracting office is located in Rockville, Maryland, the designated place of performance is in Jefferson, Arkansas.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Medical Kit Assembly and Packaging

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-368P

This contract is for the procurement of Pathogel bacteria determination test kits, which are single-use, self-contained units designed to detect coliform, E. coli, and hydrogen sulfide producing enterobacteriaceae in food, beverages, and water. The kits utilize a special gelling agent to determine both the presence or absence of bacteria and the quantitation of colony forming units, with detection limits of 1CFU/100ML for water and 1CFU/3ML for juice, providing results within 28 hours. The unit of issue is one package containing 25 kits. The items must adhere to a strict shelf life of six months, with no more than one month elapsed from the date of manufacture to the date of delivery. Storage and shipping must be maintained between 15 to 25 degrees Celsius. Packaging must meet commercial standards and Medical Marking Standard No. 1, ensuring each unit is sealed and protected from damage. The delivery requirement is 20 days after the order is received, and the supplier must specify the source and part number being provided.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, SYPHILIS DETE

Solicitation # SPE2DS-26-T-369Y

This contract is for the procurement of syphilis detection test kits designed for rapid immunochromatographic antibody testing using whole blood finger sticks. The items are issued in kits containing 20 units each, under NSN 6550-01-717-7481. The supplier must provide the source and part number and ensure the product is stored between 4 and 30 degrees Celsius. The kits have a non-extendable shelf life of 30 months, and no more than four months may have elapsed from the date of manufacture to the date of delivery. Packaging must meet commercial standards and be sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1. All labels must clearly state the contract number, lot number, manufacture date, and expiration or retest date. This acquisition is managed by the Department of Defense Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

6505--Droxidopa Capsules (VA-27-00007975)

Solicitation # 36E79726Q0004

The Department of Veterans Affairs is conducting market research to establish a national mandatory requirements contract for Droxidopa Capsules across several federal agencies, including the DoD, IHS, BOP, and FHCC. The procurement covers three strengths of capsules (100mg, 200mg, and 300mg) in 90-count bottles, with a total estimated annual usage of approximately 13,485 bottles. The government seeks a base year with up to four option years and intends to award the contract based on committed volumes to achieve pricing below FSS or Open Market rates. Eligible offerors must possess a unique eleven-digit NDC number and be able to supply products in specific unit of use packaging, featuring child-proof closures and specific bottle dimensions. Non-manufacturers must provide a letter of commitment from their manufacturer, and all contractors must have business-to-business agreements with Pharmaceutical Prime Vendors for distribution. The research also evaluates company size under NAICS code 325412 and compliance with U.S. made or Trade Agreements Act requirements. Responses are due by September 4, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Ticagrelor Tablets

Solicitation # 36E79726R0028

The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Quadrivalent Influenza Vaccine Supply (Contingency Option)Nac Pharmaceuticals, under the Department of Veterans Affairs, is seeking a subcontract for the contingency supply of quadrivalent influenza vaccines suitable for all age groups. This procurement is triggered specifically if the World Health Organization recommends the quadrivalent version and trivalent vaccines are unavailable. All supplied vaccines must maintain full FDA labeling and adhere to current Good Manufacturing Practice compliance. The solicitation was posted on August 25, 2026, with a response deadline of September 8, 2026. This requirement falls under NAICS code 325413 for pharmaceutical preparation.

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

Cold Chain Logistics and Vaccine Distribution (Domestic & Overseas)This subcontract opportunity with Nac Pharmaceuticals for the Department of Veterans Affairs involves the cold chain logistics and distribution of vaccines to federal health facilities. The scope of work requires temperature-controlled transportation to maintain a strict range between 2°C and 8°C, utilizing FOB Destination delivery terms for shipments across the United States, Puerto Rico, and the Philippines. The project falls under NAICS code 484121 and was posted on August 25, 2026. Interested parties must submit their responses by the deadline of September 8, 2026, at 7:30 PM.

General Freight Trucking, Long-Distance, Truckload

POSTED

DEADLINE

Supply of Trivalent Influenza Vaccine (Pediatric Population)Nac Pharmaceuticals, under the Department of Veterans Affairs, is seeking a subcontractor for the manufacture and supply of a split-virus trivalent influenza vaccine. This specific vaccine is designed for children aged 6 to 35 months and must be provided in pre-filled single-dose syringes that are both latex-free and preservative-free to ensure pediatric safety compliance. The solicitation was posted on August 25, 2026, with a response deadline of September 8, 2026. This procurement falls under NAICS code 325413, focusing on the production of pharmaceutical preparations.

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

Supply of Trivalent Influenza Vaccine (Senior Population)Nac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking a subcontractor for the manufacture and supply of a trivalent influenza vaccine specifically designed for individuals aged 65 and older. The required vaccine must be FDA-approved and either high-dose or adjuvanted, delivered in pre-filled single-dose syringes that are both latex- and preservative-free. This procurement opportunity falls under NAICS code 325413. The solicitation was posted on August 25, 2026, with a response deadline set for September 8, 2026.

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

6505--2027-2028 Influenza Virus Vaccine

Solicitation # 36E79726R0035

The VA National Acquisition Center intends to issue Request for Proposal 36E79726R0035 for the procurement of Influenza Virus Vaccines for the 2027-2028 season. This unrestrictive procurement supports the Department of Veterans Affairs, State Veteran Homes option 2, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The requirement covers three specific vaccine presentations: a general dose for persons 36 months and older, a dose specifically for persons 65 years and older, and a pediatric dose for children 6 months to 35 months. Total estimated annual usage across all agencies is approximately 276,559 boxes of 10 syringes. Evaluation and award will be conducted by solicitation line item, and offerors must provide the full quantity for any line item they bid on. Pricing must include the Cost Recovery Fee and Federal Excise Tax, with identical unit pricing required for the same presentation across different line items. Delivery is FOB Destination to facilities in the United States, the Philippines, and Puerto Rico. Most facilities require a split delivery schedule between August 15 and October 15, 2027, while the Captain James A. Lovell Federal Health Care Center must receive its full quantity by September 15, 2027. The solicitation is expected to be issued around September 8, 2026, with a closing date of September 24, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Tacrolimus Capsules

Solicitation # 36E79726R0033

The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement for Tacrolimus Capsules to establish an uninterrupted source of supply for multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded to a single responsible offeror and follows FAR Part 12 commercial item procedures. The period of performance consists of a one-year base period with four pre-priced one-year option periods. Distribution of the pharmaceuticals will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers three capsule strengths with estimated annual quantities of 51,904 bottles of 0.5mg, 142,788 bottles of 1mg, and 5,207 bottles of 5mg, all in package sizes of 100. Strict labeling requirements are in place, requiring the offeror to provide the exact drug name and a unique NDC number belonging to the offeror. The contractor's label must be the only label on the product, and affixing labels over existing labels is strictly prohibited. The solicitation is managed by the Enterprise Procurement Office in Hines, Illinois, with a tentative closing date of September 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Logistics and Distribution via Pharmaceutical Prime Vendor Programs

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Labeling and Over-Label Adhesion Services

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Unit-of-Use Pharmaceutical Bottle Supply

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply of Lisinopril Tablets

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE